期刊
MEDCHEMCOMM
卷 7, 期 3, 页码 457-463出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c5md00498e
关键词
-
资金
- Academy of Finland [264020, 265481]
- Magnus Ehrnrooth Foundation [ME2012n44]
- Academy of Finland (AKA) [265481, 264020, 265481, 264020] Funding Source: Academy of Finland (AKA)
Derivatives of dehydroabietic acid bearing different amino acids scaffolds have potent antiprotozoal activity against Leishmania donovani and Trypanosoma cruzi, with good to high selectivity, and can therefore be regarded as good models for further development into new drugs to fight leishmaniasis and Chagas disease. Several of the tested compounds were able to kill parasites residing inside cells, with IC50 values ranging from 2.3 to 9 mu M (L. donovani) and 1.4 to 5.8 mu M (T. cruzi), reflecting their ability to fight these infections at the relevant stage responsible for disease. One of the compounds, bearing a 3-pyridyl-Dalanine side chain, was 1.5-fold more potent against T. cruzi amastigotes residing in L6 cells than the reference compound benznidazole.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据